Cmpx analyst
WebApr 6, 2024 · According to the issued ratings of 6 analysts in the last year, the consensus rating for Compass Therapeutics stock is Buy based on the current 6 buy ratings for … WebView the latest Compass Therapeutics Inc. (CMPX) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Cmpx analyst
Did you know?
WebAnalyst Ratings are available for US and Canadian equities. Unlike Barchart Opinions (which calculate the Buy/Sell rating using a variety of short-medium and long-term …
WebApr 10, 2024 · 6 Wall Street analysts have issued 12-month price objectives for Compass Therapeutics' shares. Their CMPX share price forecasts range from $8.00 to $10.30. On … WebApr 6, 2024 · View Compass Therapeutics, Inc CMPX investment & stock information. Get the latest Compass Therapeutics, Inc CMPX detailed stock quotes, stock data, Real …
WebAnalyst Rating / Earnings Estimates. Current Rating See More. Strong Buy. Based on 8 analysts offering recommendations. Earnings Estimates - Current Qtr 03/31/23 ... BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary... WebApr 13, 2024 · To get a sense of who is truly in control of Compass Therapeutics, Inc. (NASDAQ:CMPX), it is important to understand the ownership structure of the business. The group holding the most number of ...
WebApr 11, 2024 · Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Rating) has received an average rating of "Buy" from the seven ratings firms that are currently covering the firm, Marketbeat.com reports.Six analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have issued ratings on the stock in the last year …
WebFeb 7, 2024 · Find out the current price target and stock forecast for Compass Therapeutics, Inc. (CMPX) ... Analyst Upgrades/Downgrades. Date Brokerage Firm Analyst From To; 1/31/2024: Jefferies & Co. chill medicated near meWebCompass Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CMPX updated stock price target summary. chill medicated lollipopsWebPrice target 9.19 0.00 0.00% The 7 analysts offering 1 year price forecasts for CMPX have a max estimate of — and a min estimate of —. Analyst rating Based on 8 analysts giving stock ratings to CMPX in the past 3 months. Neutral Sell Buy Strong sell Strong buy Strong buy Strong buy 0 Buy 0 Hold 0 Sell 0 Strong sell 0 EPS Annual Quarterly 0 grace sandals by sofftWebApr 12, 2024 · Simply Wall St. Published April 12, 2024. Source: Shutterstock. When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 16x, you may consider Enact Holdings, Inc. ( NASDAQ:ACT) as a highly attractive investment with its 5.5x P/E ratio. Nonetheless, we'd need to dig a little deeper to … chill medicated extreme rub 1500mgWebMar 14, 2024 · The company has drugged over 40 immune targets and generated a diverse pipeline of monoclonal and multispecific therapeutic candidates with potential to … chill medicated massage oilWeb(3) 对栅格图层：“计算2”进行重分类运算（执行命令Spatial Analyst Tools－Reclassify命令），使得原来的True（1）值为0，False（0）值为1，得到新的栅格图层：Reclass of 计算2。 图14 重分类运算 (4) 将图层“计算”与“Recla grace sarasota churchWebApr 10, 2024 · Compass Therapeutics Inc. (NASDAQ:CMPX)’s beta value is currently sitting at 0, while the Average True Range indicator is currently displaying 0.20. With analysts defining $8.00-$11.00 as the low and high price targets, we arrive at a consensus price target of $9.19 for the trailing 12-month period. chill medicated body rub 500 mg